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Evidence is emerging that neuronal nicotinic acetylcholine receptors (nAChRs) in 
the mesolimbic dopamine (DA) system are involved in mediating the reinforcing effects 
of alcohol.  Midbrain DA neurons express high levels of α6 subunit-containing nAChRs 
that modulate DA transmission, implicating their involvement in reward-related 
behaviors.  The present study assessed the role of α6-containing nAChRs in modulating 
alcohol reward using transgenic mice expressing mutant, hypersensitive α6 nAChR 
subunits (α6L9′S mice).  α6L9′S mice and littermate controls were tested in three well-
established models of alcohol reward: 24-hr two-bottle choice drinking, drinking in the 
dark (DID), and conditioned place preference (CPP).  Confocal microscopy and patch-
clamp electrophysiology were used to demonstrate the localization and function of 
hypersensitive α6 subunit-containing nAChRs.  Results indicate that female α6L9′S mice 
showed significantly higher alcohol intake at low concentrations of alcohol (3% and 6%) 
in the two-bottle choice procedure.  Both male and female α6L9′S mice drank 
significantly more in the DID procedure and displayed an alcohol-induced place 
preference using a low dose of alcohol (0.5 g/kg) that was ineffective in littermate 
controls.  Confocal microscopy showed that α6 subunit-containing nAChRs are 
selectively expressed on ventral tegmental area (VTA) DAergic, but not GABAergic 
neurons.  Patch-clamp electrophysiology demonstrated that VTA DA neurons of α6L9′S 
mice are hypersensitive to ACh.  Collectively, these results suggest that α6L9′S mice are 
more sensitive to the rewarding effects of alcohol, and suggest that VTA α6 subunit-
containing nAChRs modulate alcohol reward. Thus, α6 subunit-containing nAChRs may 
be a promising therapeutic target for treatment of alcohol use disorders. 
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Introduction 
 Alcohol and nicotine are often used together (Grant et al., 2004), possibly because 
the two drugs interact to influence the rewarding effects of one or both substances (Little, 
2000).  Nicotine exerts its effects on nicotinic acetylcholine receptors (nAChRs), which 
are widely expressed in the central nervous system.  nAChRs can modulate the 
excitability of neurons, ultimately affecting the release of neurotransmitters, including 
acetylcholine (ACh), GABA (Mcclure-Begley et al., 2009), glutamate (Garduno et al., 
2012, Mansvelder & Mcgehee, 2000), norepinephrine (Azam & Mcintosh, 2006), and 
serotonin (Gotti et al., 2006).  Importantly, presynaptic nAChRs located in the 
mesolimbic reward pathway can strongly modulate dopamine (DA) release (Drenan et 
al., 2010, Drenan et al., 2008, Grady et al., 2002, Jackson et al., 2009, Salminen et al., 
2007).   
Alcohol elevates DA levels in the nucleus accumbens (Soderpalm et al., 2009), a 
brain area involved in the reinforcing properties of alcohol (reviewed by Wise, 1998).  
Evidence suggests that nAChRs in the ventral tegmental area (VTA) may underlie 
elevated alcohol-induced accumbal DA levels.  Ericson and colleagues (2008) showed 
that when the nonselective nAChR antagonist mecamylamine was locally administered to 
the anterior VTA, it blocked alcohol-induced increases in accumbal DA levels, 
suggesting that nAChRs in the VTA be may involved in modulating alcohol reward.  
Mecamylamine also reduced alcohol drinking in rodents (Blomqvist et al., 1996, Ericson 
et al., 1998, Hendrickson et al., 2010) and humans (Chi & De Wit, 2003, Young et al., 
2005).  The FDA-approved smoking cessation aid varenicline, a partial agonist at α4β2* 
and α6β2* nAChRs (* indicates that other subunits may be present in the pentameric 
 5 
receptor) (Mihalak et al., 2006), reduced alcohol intake in rodents (e.g., Hendrickson et 
al., 2010) and in humans (Mckee et al., 2009).  However, because both mecamylamine 
and varenicline are not selective antagonists, it is not clear which nAChR subtypes are 
involved in alcohol drinking behavior.   
The mesolimbic DA system, consisting in part of DA neurons in the VTA and 
their projections to nucleus accumbens, is crucial to alcohol reward (e.g., Brodie et al., 
1999, Gessa et al., 1985).  α6* nAChRs are enriched in the mesolimbic reward pathway, 
and previous studies support the claim that α6* nAChRs, unlike α4 (non-α6)* nAChRs, 
are selectively expressed in DA neurons but not in local GABA neurons that inhibit DA 
cells.  Recently, Drenan and colleagues (2008) created mice with mutated α6 nAChR 
subunits (α6L9′S mice) in order to selectively amplify the downstream effects of 
activating α6* nAChRs.  In α6L9′S mice, α6* nAChRs are markedly hypersensitive to 
nicotine, showing greater nicotine-stimulated DA release in synaptosome experiments 
and larger inward currents in response to local application of nicotine to patch-clamped 
VTA DA neurons in brain slices (Drenan et al., 2008).  These results provide evidence 
that α6* nAChRs located on VTA DAergic neurons modulate DA transmission.   
Indirect evidence suggests that α6* nAChRs may play an important role in 
modulating alcohol reward-related behaviors.  α-conotoxin MII, an antagonist at both 
α3β2* and α6* nAChRs, reduced both voluntary drinking (Larsson & Engel, 2004) and 
operant responding (Lof et al., 2007) for alcohol.  However, because α-conotoxin MII is 
not perfectly selective for α6* vs. α3* nAChRs, complementary approaches are necessary 
to confirm the role of specific nAChR subunits in modulating behavior.  Mutant mice 
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with hypersensitive α6* nAChRs provide an excellent opportunity to evaluate the specific 
role of the α6 subunit in alcohol reward.   
The purpose of the present study was to assess the involvement of α6* nAChRs in 
modulating alcohol reward by comparing α6L9′S mice to littermate controls in three 
well-established models of alcohol reward: 24-hr two-bottle choice drinking, drinking in 
the dark (DID), and alcohol-induced conditioned place preference (CPP).  Confocal 
microscopy and patch-clamp electrophysiology were used to demonstrate the localization 
and function of hypersensitive α6* nAChRs.   
 
Materials and Methods 
 
Subjects  
6L9′S bacterial artificial chromosome (BAC) transgenic mice were constructed 
as previously described (Drenan et al., 2008).  Briefly, an ectopic BAC containing a 
mutant, L9′S allele of the mouse 6 nAChR subunit gene was introduced into fertilized 
FVB/N embryos and implanted into pseudopregnant Swiss-Webster surrogates.  The 
insertion site within the mouse genome is unknown.  Founder animals were back-crossed 
to C57BL/6 12 to 15 times prior to these studies.  Although >90% of the genome is 
expected to be C57BL/6 following this many rounds of back-crossing, elimination of 
FVB/N allelic DNA immediately adjacent to the BAC insertion site is not likely.  -
conotoxin MII binding experiments demonstrated that 6* nAChRs are faithfully 
expressed in their correct anatomical locations and are not overexpressed in 6L9′S mice 
(Drenan et al., 2010, Drenan et al., 2008).  Both male and female mice were used in the 
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current experiment with ages ranging from 64 to 193 days old at the time of experimental 
procedures.  Mice were group housed (unless otherwise indicated) and had free access to 
food (Rodent Lab Diet 5001, Purina Mills Inc., St. Louis, MO, USA) and water in the 
home-cage.  Ambient temperature in the colony and experimental rooms was maintained 
at 21±2°C.  Efforts were made to minimize any pain and discomfort to the mice.  All 
experiments were conducted in accordance with the guidelines for care and use of 
animals provided by the National Institutes of Health (NIH), and all procedures were 
approved by the Purdue University Institutional Animal Care and Use Committee. 
 
Drugs 
Alcohol (95% v/v) was diluted with tap water (drinking studies) or saline (CPP 
studies) to obtain the desired concentrations (3%, 6%, 10%, 20% v/v).  For the place 
conditioning study, alcohol was administered intraperitoneally (i.p.) in doses of 0.5 and 
2.0 g/kg of body weight with injection volumes of 3.15 and 12.6 ml/kg (20% v/v), 
respectively.   
 
Place conditioning apparatus 
The place conditioning apparatus has been utilized in prior place conditioning 
studies with mice (e.g., Powers et al., 2010).  The apparatus consisted of 12 identical 
Plexiglas boxes (43.2 X 1.6 X 25.4 cm) enclosed in separate ventilated sound- and light-
attenuated chambers (76.2 X 50.8 X 20.3 cm).  The floor of each box consisted of 
interchangeable halves with distinct floor textures.  One floor texture (the Grid floor) 
consisted of 4 mm steel rods mounted 3.5 mm apart and the other floor texture (the Hole 
 8 
floor) was made up of perforated 16 gauge stainless steel with 6.4 mm holes on 9.5 mm 
staggered centers.  Locomotor activity and side position (left or right) for each mouse 
was continuously monitored in each box with an open field activity frame (SmartFrame 
Low Density, Lafayette Instrument Co, Lafayette, IN, USA), that contained infrared 
photobeams along the length and width of each frame (internal frame dimensions: 24.1 X 
45.7 cm).  Ventilation fans in each box masked outside noise.   
 
Study procedures 
24-hr continuous-access alcohol drinking 
Mice [n=35; 17 α6L9′S (9 male/8 female) and 18 non-Tg (10 male/8 female)] 
were singly housed for 7 days with access to two water-filled tubes (25 ml fitted with 
metal drinking spouts) in order to habituate them to the experimental environment.  On 
the 8
th
 day, one of the water tubes was replaced with an alcohol tube for each mouse.  
Alcohol concentration was increased every 4 days: days 1 - 4 (3%), days 5 - 8 (6%), days 
9 – 12 (10%), and days 13 - 16 (20%).  Every 2 days, mice were weighed, drinking 
solutions were replaced, and bottle position was alternated to avoid the development of a 
side preference (Kamens et al., 2010).  Evaporation/leakage was estimated from tubes 
placed on empty cages, and mean volume lost was subtracted from individual drinking 
values before analysis.   
 
Drinking in the dark (DID) 
Drinking in the dark experiments were conducted as previously described 
(Rhodes et al., 2005).  The same mice used in the 24-hr continuous-access alcohol 
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drinking study remained singly housed for 33 days with normal water bottles.  Mice then 
received one water-filled drinking tube on the home cage for 7 days.  On days 8 through 
11, body weights were measured and the water tube for each mouse was replaced with a 
20% v/v alcohol tube two hours after lights off (lights off at 0945).  Mice had access to 
alcohol for 2 hrs.  Amount of alcohol consumed was recorded daily after each 2-hr 
session.   
 
Alcohol-induced CPP 
The place conditioning procedure consisted of 1 pretest, 8 conditioning sessions, 
and 1 posttest.  All phases of the experiment were conducted on consecutive days except 
that a 48 hr break separated the first four and the second four conditioning sessions.  
Experimental groups were counterbalanced by genotype, sex, order of exposure to the 
conditioning stimulus (CS), box enclosure and floor position (i.e., left vs. right side of the 
box).  All animals were transferred on a cart to the procedure room 30 min before the 
start of experimental procedures each day.   
Pretest (Day 1).  Initial unconditioned preference for each CS (Grid vs. Hole) was 
assessed 24 hr prior to the start of the first conditioning trial.  Subjects were injected (i.p.) 
with saline (at a volume equal to a 0.5 or 2.0 g/kg dose of alcohol, depending on the 
experiment) and placed in the testing box with free access to both floor types for 60 min.  
Conditioning Sessions (Days 2-11).  Mice underwent a differential place 
conditioning procedure in which they were randomly assigned to one of two conditioning 
subgroups within each experimental subgroup.  Each conditioning subgroup received 5 
minutes of exposure to either a Grid or Hole floor paired with alcohol treatment (4 CS+ 
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conditioning sessions) and the other floor type paired with saline (4 CS− conditioning 
sessions) on alternating days, for a total of 8 conditioning sessions.  The floors and inside 
of the box were wiped with a damp sponge between each subject. 
Separate experiments were run for each dose of alcohol (0.5 and 2.0 g/kg), but all 
procedures were identical.  A total of 32 mice [17 α6L9′S (8 male/9 female) and 15 non-
Tg (4 male/11 female)] were used for the 0.5 g/kg experiment, and 28 mice [17 α6L9′S (9 
male/8 female) and 11 non-Tg (3 male/8 female)] were used for the 2.0 g/kg experiment.  
The low dose of alcohol (0.5 g/kg) was chosen because we hypothesized that α6L9′S 
mice would be more sensitive to alcohol reward, and a 0.5 g/kg dose is below the 
threshold for producing alcohol-induced CPP in C57BL/6 mice (e.g., Cunningham et al., 
1992, Wrobel, 2011).  The 2.0 g/kg dose was used as a positive control.  
Posttest (Day 12).  Mice were tested for CPP 24 hrs after their final conditioning 
session.  As in the pretest, mice had free access to both floors in the same position for 60 
min.  Mice received an injection of saline (equal volume to a 0.5 or 2.0 g/kg dose of 
alcohol) directly before being placed in the apparatus to match cues during conditioning. 
 
Brain Slice Preparation for Electrophysiology 
Brain slices were prepared as previously described (Engle et al., 2012).  α6L9′S 
and non-Tg mice were genotyped at 21-28 days after birth.  Mice were anesthetized with 
sodium pentobarbital (100 mg/kg; i.p.) followed by cardiac perfusion with oxygenated 
(95% O2/5% CO2), 4°C NMDG-recovery solution containing (in mM): 93 n-methyl D-
glucamine, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 Na
+
 ascorbate, 
2 thiourea, 3 Na
+
 pyruvate, 10 MgSO4•7H2O, 0.5 CaCl2•2H2O (300-310 mOsm, pH 7.3-
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7.4).  Brains were removed and retained in 4°C NMDG-recovery solution for 1 min.  
Coronal slices (250 μm) were cut with a microslicer (DTK-Zero 1; Ted Pella, Redding, 
CA).  Brain slices recovered for 12 min at 33°C in oxygenated NMDG-recovery solution, 
after which they were held until recording in HEPES holding solution containing (in 
mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 Na
+
 
ascorbate, 2 thiourea, 3 Na
+
 pyruvate, 2 MgSO4•7H2O, 2 CaCl2•2H2O (300-310 mOsm, 
pH 7.3-7.4).  Coordinates for recordings in SNc/VTA were within the following range: (-
3.8 to -2.9 mm from bregma, 4.0 to 4.8 mm from the surface, and 0.0 to 2.0 mm from the 
midline). 
 
Immunohistochemistry and Confocal Microscopy 
Transgenic mice expressing α6* nAChR subunits fused in-frame with green 
fluorescent protein (GFP) (α6GFP mice; 2 male/2 female) were anesthetized with sodium 
pentobarbital (100 mg/kg; i.p.) and transcardially perfused with 15 ml of ice-cold PBS 
followed by 25 ml of ice-cold 4% paraformaldehyde (PFA) in PBS. Brains were removed 
and postfixed for 2 h at 4°C.  Coronal sections (50 μm) were cut on a microslicer and 
collected into PBS.  Sections were permeabilized (20 mM HEPES, pH 7.4, 0.5% Triton 
X-100, 50 mM NaCl, 3 mM MgCl2, 300mM sucrose) for 1 h at 4°C, blocked (0.1% 
Triton X-100, 5% donkey serum in TBS) for 1 h at RT, and incubated overnight at 4°C in 
solutions containing primary antibodies (diluted in 0.1% Triton X-100, 5% donkey serum 
in TBS).  Primary antibodies and final dilutions were as follows: 1:500 rabbit anti-GFP 
(A11122; Invitrogen), 1:500 sheep anti-tyrosine hydroxylase (TH; AB1542, Millipore), 
1:500 mouse anti-GAD67 (MAB5406; Millipore).  Sections were washed three times for 
 12 
10 min each in TBST (0.1% Triton X-100 in TBS) followed by incubation at RT for 1 hr 
with secondary antibodies (diluted in 0.1% Triton X-100, 5% donkey serum in TBS).  
Secondary antibodies and final dilutions were as follows: 1:1000 goat anti-rabbit Alexa 
488 (A11008; Invitrogen), 1:1000 donkey anti-sheep Alexa 555 (A21436; Invitrogen), 
1:1000 donkey anti-mouse Alexa 555 (A31570; Invitrogen).  Sections were then washed 
four times in TBST for 10 min each.  All sections were mounted on slides and 
coverslipped with Vectashield (Vector Laboratories), then imaged with a Nikon (Nikon 
Instruments) A1 laser-scanning confocal microscope system.  Nikon Plan Apo 10X air 
and 60X oil objectives were used.  Alexa 488 was excited with an argon laser at 488 nm, 
and Alexa 555 was excited with a yellow solid-state laser at 561nm.  
 
Patch Clamp Electrophysiology 
Patch clamp electrophysiology was carried out as previously described (Engle et 
al., 2012) using tissue collected from adult mice (10 α6L9′S mice and 5 non-Tg mice).  
Each recorded cell within a slice was treated as a separate experiment, and each animal 
yielded between 1 and 6 recorded cells.  Patch clamp experiments were not segregated by 
sex.  A single slice was transferred to a 0.8 ml recording chamber (Warner Instruments, 
RC-27L bath with PH-6D heated platform), and slices were superfused throughout the 
experiment with standard recording ACSF (1.5–2.0 ml/min) containing (in mM): 124 
NaCl, 2.5 KCl, 1.2 NaH2PO4, 24 NaHCO3, 12.5 glucose, 2 MgSO4•7H2O, 2 CaCl2•2H2O 
(300-310 mOsm, pH 7.3-7.4).  Cells were visualized with an upright microscope (FN-1; 
Nikon) using infrared or visible differential interference contrast (DIC) optics. Patch 
electrodes were constructed from Kwik-Fil borosilicate glass capillary tubes (1B150F-4; 
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World Precision Instruments, Inc.; Sarasota, FL) using a programmable microelectrode 
puller (P-97; Sutter Instrument Co.; Novato, CA).  The electrodes had tip resistances of 
4.5–8.0 MΩ when filled with internal pipette solution (pH adjusted to 7.25 with Tris 
base, osmolarity adjusted to 290 mOsm with sucrose) containing: 135 mM K
+
 gluconate, 
5 mM EGTA, 0.5 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 2 mM Mg-ATP, and 0.1 
mM GTP.  Whole-cell recordings were taken at 32°C with an Axopatch 200B amplifier, 
a 16-bit Digidata 1440A A/D converter, and pCLAMP 10.3 software (all Molecular 
Devices Axon; Sunnyvale, CA).  Data were sampled at 5 kHz and low-pass filtered at 1 
kHz.  The junction potential between the patch pipette and the bath solution was nulled 
immediately prior to gigaseal formation.  Series resistance was uncompensated.   
VTA DAergic neurons were identified as previously described (Drenan et al., 
2008).  These neurons typically exhibit broad spikes (> 2 msec), slow tonic firing (1 to 6 
Hz) in coronal slice preparation, expression of significant Ih currents at hyperpolarized 
potentials, and significant sag responses in current clamp mode following injection of 
hyperpolarizing current.  To examine the function of somatic nAChRs, acetylcholine was 
locally applied using a Picospritzer III (General Valve; Fairfield, NJ).  Using a high-
resolution micromanipulator, (Sutter Instruments; Novato, CA), the pipette tip was 
moved within 20-40 μm of the recorded cell 1-2 sec before drug application.  ACh-
containing ACSF recording solution was then puffed at 10–20 psi for 250 ms.  




Behaviors were analyzed using analysis of variance (ANOVA) with the 
significance level set at p≤0.05. Between-group factors included genotype and sex.  
Within-group factors included concentration phase (3%, 6%, 10%, and 20%), day, floor 
type (Grid or Hole), conditioning session (1-8), trial (4: one CS+ conditioning session 
and one CS- conditioning session), trial type (CS+ and CS-), block (2-day drinking 
averages), test (pretest and posttest), time bin (first and last 30 min) or min, where 
applicable.  Only significant interactions including genotype are reported and followed-
up with lower–order ANOVAs and t-tests, where applicable.  Preference test data were 
averaged into 30 min time bins before analysis since treatment effects on the expression 
of CPP can change over the course of the 60-min preference test (e.g., Chester et al., 
1998, Powers et al., 2010).  Pearson correlations between CS+ time and locomotor 
activity during the posttest were conducted because locomotor activity can affect the 
expression of CPP (Gremel & Cunningham, 2007).  Concentration-response curves for 
ACh-elicited inward currents in VTA neurons were derived by fitting mean peak current 
values for each ACh concentration to the Hill equation. 
 
Results 
24-hr continuous-access  
Alcohol intake. Similar to (Kamens et al., 2010), mice were given access to 
escalating concentrations of alcohol over a 16-day test period in a two-bottle choice 
paradigm.  Data from non-Tg mice (1 male and 1 female) were excluded from analysis 
due to restricted fluid flow from the sipper tube, leaving a total of 33 mice included in 
analyses: 17 α6L9′S (9 male/8 female) and 16 non-Tg (9 male/7 female).  Alcohol intake 
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(g/kg) was averaged into 2-day blocks to simplify data presentation (Figure 1a).  The 
ANOVA [genotype (2) X sex (2) X concentration phase (4) X block (2: within each 
concentration)] indicated that females drank more than males [F(1,29)=23.0, p<0.01] and 
that intake increased with increasing alcohol concentrations [F(3,87)=34.9, p<0.001].  A 
significant four-way interaction [F(3, 87)=4.7, p<0.01] was also found, and three-way 
ANOVAs (genotype X sex X block) within each concentration yielded significant three-
way interactions at both the 3% [F(1,29)=4.2, p=0.001] and 6% [F(1,29)=7.9, p=0.01] 
concentrations, but not at the 10% or 20%.  Follow-up ANOVAs (genotype X sex) at 
each of the 2 blocks within the 3% and 6% concentrations yielded a main effect of 
genotype for block 1 [3% concentration; F(1, 29)=5.1, p<0.01; α6L9′S<non-Tg] and 
genotype X sex interactions for blocks 2 [3% concentration; F(1, 29)=5.4, p<0.05] and 4 
[6% concentration; F(1, 29)=7.0, p=0.01].  The interactions at blocks 2 and 4 resulted 
from female α6L9′S mice consuming more alcohol than female non-Tg mice 
[Fs(1,13)>11.5, ps<0.01].   
Water intake. Water intake (ml/kg) was averaged into 2-day blocks, as was done 
for alcohol.  The ANOVA [genotype (2) X sex (2) X concentration phase (4) X block (2: 
within each concentration)] uncovered a significant genotype X concentration phase X 
block interaction [F(3,87)=9.8, p<0.001].  Follow-up two-way ANOVAs (genotype X 
block) within each concentration phase indicated significant genotype X block 
interactions for the 3% and 6% concentrations [Fs(1,31)>8.2, ps<0.01].  One-way 
ANOVAs comparing genotype at each block within the 3% and 6% concentration phases 
indicated that non-Tg drank significantly more water than α6L9′S mice on blocks 2 [3% 
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concentration; F(1, 29)=17.7, p<0.001] and 4 [6% concentration; F(1, 29)=19.1, 
p<0.001], mirroring alcohol intake (data not shown). 
Total fluid intake. Total fluid intake (ml/kg: Figure 1b) was averaged into 2-day 
blocks, as was done for alcohol and water.  ANOVA [genotype (2) X sex (2) X 
concentration phase (4) X block (2: within each concentration)] indicated that females 
drank more total fluid that males [F(1,29)=52.3, p<0.001].  A significant four-way 
interaction [F(3,87)=2.7, p<0.05] was followed-up with three-way ANOVAs within each 
concentration phase, but these analyses showed no significant effects.  
 
DID 
 Mice removed from the data set in the 24- hour drinking study (blocked tubes) 
were included in the DID study, for a total of 35 mice: 17 α6L9′S (9 male/8 female) and 
18 non-Tg (10 male/8 female).  A three-way ANOVA [genotype (2) X sex (2) X day (4)] 
of alcohol intake (g/kg) yielded a main effect of genotype [F(1, 31)=4.8, p<0.05], 




0.5 g/kg  
Pretest preference. Analysis of the raw time spent on the Grid and Hole floors 
[genotype (2) X sex (2) X floor type (2) X time bin (2: first and last 30 min) ANOVA] 
yielded no effects indicating that mice did not show an unconditioned preference for 
either floor type.   
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Pretest activity. Analysis of pretest locomotor activity [genotype (2) X sex (2) X 
time bin (2: first and last 30 min) ANOVA] indicated that non-Tg mice were more active 
than α6L9′S mice [F(1, 28)=4.4, p<0.05], that females were more active than males [F(1, 
28)=4.3, p<0.05], and that activity was lower during the last 30 min compared to the first 
30 min [F(1, 28)=115.8; p<0.01] (data not shown).   
Conditioning activity.  Data from one female α6L9′S mouse was removed from 
conditioning activity analysis due to equipment malfunction on the second CS+ 
conditioning trial.  Analysis of locomotor activity on CS+ and CS- trials [genotype (2) X 
sex (2) X trial (4) X trial type (2) ANOVA] indicated a main effect of sex [F(1, 27)=6.4, 
p<0.05; females>males] and a genotype X trial interaction [F(3, 81)=4.0, p=0.01].  
Follow-up analyses of genotype within each trial did not show significance; the 
interaction was due to a genotype dependent difference in reduced activity across trials.  
A genotype X sex X trial type interaction [F(1, 27)=9.6, p<0.01] was also found. 
Follow-up analyses comparing genotype and sex within each trial type showed females 
were more active than males on both trial types [Fs(1,27)>5.7, ps<0.05].  Comparing sex 
and trial type within each genotype indicated that α6L9′S females were more active than 
α6L9′S males [F(1,14)=4.4, p=0.05], and non-Tg mice displayed greater activity on CS+ 
than on CS- trials [F(1,13)=4.9, p=0.05] (Figure 3); α6L9′S mice did not show a 
difference in activity levels between CS+ and CS- trial types.  
 Posttest preference.  ANOVAs comparing change in time spent on the CS+ floor 
from the pretest to the posttest [genotype (2) X sex (2) X test (2) X time bin (2: first and 
last 30 min)] indicated a significant genotype X sex X test interaction [F(1,28)=6.4, 
p<0.05], but follow-up analyses did not reach significance.  There was also a genotype X 
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test X time bin interaction [F(1,28)= 4.9, p<0.05].  Two-way ANOVAs (genotype X test) 
within each time bin indicated a significant two-way interaction in the last 30 min only 
[F(1,28)=6.1, p<0.05].  Analysis of test within each genotype indicated a significant CPP 
in α6L9′S mice [F(1,16)=4.4, p=0.05], but not in non-Tg mice (Figure 4).  
Posttest activity. Analysis of posttest locomotor activity [genotype (2) X sex (2) X 
time bin (2: first and last 30 min) ANOVA] indicated a genotype X time bin interaction 
[F(1,28)=11.8, p<0.01].  Genotype comparisons within each time bin indicated that non-
Tg mice were more active than α6L9′S mice during the last 30 minutes only 
[F(1,30)=13.6, p<0.01]; there was a trend for the same genotype difference during the 
first 30 min (p=0.06) (data not shown).   
Pearson correlations.  Correlations of CS+ time and posttest activity during the 
first and last 30 min indicated no significant relationship.  The same analyses run within 
each genotype also indicated no significant relationships.  
 
2.0 g/kg  
Pretest preference. Analysis of the raw time spent on the Grid and Hole floors 
[genotype (2) X sex (2) X floor type (2) X time bin (2: first and last 30 min) ANOVA] 
yielded a genotype X sex X time bin interaction [F(1, 24)=4.7, p<0.05], but no floor type 
interaction, indicating that mice did not show an unconditioned preference for either floor 
type. 
Pretest activity. Analysis of pretest locomotor activity [genotype (2) X sex (2) X 
time bin (2: first and last 30 min) ANOVA] indicated a significant sex X time bin 
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interaction [F(1,24)=8.4, p<0.01], due to a greater reduction in locomotor activity in 
males than females across the test session (data not shown). 
Conditioning activity.  Analysis of locomotor activity on CS+ and CS- trials 
[genotype (2) X sex (2) X trial (4) X trial type (2) ANOVA] indicated a significant trial X 
trial type interaction [F(3,72)=9.7, p<0.01].  Comparing trial within each trial type 
indicated a significant reduction in activity across CS- trials only [F(3,81)=20.5, p<0.01].  
Comparing trial type within each trial indicated mice were significantly more active on 
CS+ days than CS- days for trials 2-4 [Fs(1, 27)>20.1, ps<0.01 (Figure 5)]. 
Posttest preference. ANOVAs comparing change in time spent on the CS+ floor 
from the pretest to the posttest [genotype (2) X sex (2) X test (2) X time bin (2: first and 
last 30 min)] indicated a main effect of sex [F(1,24)=6.3, p<0.05; male>female] and a 
strong trend for a main effect of test [F(1,24)=4.0, p=0.057; posttest >pretest] (Figure 6).   
Posttest activity. Analysis of posttest locomotor activity [genotype (2) X sex (2) X 
time bin (2: first and last 30 min) ANOVA] uncovered a main effect of time bin 
[F(1,24)=33.6, p<0.01], indicating lower activity during the last than the first 30 min of 
the posttest (data not shown). 
Pearson correlations.  Correlations of CS+ time and posttest activity during the 
first and last 30 min indicated a significant negative relationship during the first 30 min 
(r=-0.39, n=28, p<0.05).  The same analyses run within each genotype indicated 
significant negative relationships for non-Tg mice only, within both 30 min periods (rs=-
0.75, ns=11, ps=0.01).  
 
Immunohistochemistry and Confocal Microscopy 
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To support the claim that α6* nAChRs are selectively expressed in DA neurons 
but not local GABA neurons, we studied α6GFP transgenic mice.  α6GFP mice faithfully 
recapitulate the known, endogenous expression pattern of α6* nAChR subunits in the 
mouse brain (Mackey et al., 2012).  We stained ventral midbrain sections in α6GFP mice 
with anti-GFP antibodies to localize α6* nAChRs, and we co-stained these sections for 
either tyrosine hydroxylase (TH; a marker of DA neurons) or glutamic acid 
decarboxylase 67 (GAD-67; a marker of GABAergic neurons).   
Confocal microscopy showed the selective expression of α6* nAChRs (Figure 7).  
Analysis of stained sections showed that while α6* nAChRs are indeed enriched in DA 
neurons in VTA and the adjacent substantia nigra pars compacta (SNc) (Figure 7a), 
GABAergic neurons in ventral midbrain do not express α6* nAChRs (Figure 7b).  High-
resolution confocal images at the border between SNc and SNr show that GFP-tagged α6 
nAChR subunits are not localized in GAD67-positive, GABAergic neurons (Figure 7c).  
Both male and female brains were analyzed.  We found no sex differences and no 
evidence for mis-expression of 6GFP subunits in brain areas not known to express this 
subunit (data not shown). 
 
Patch Clamp Electrophysiology 
α6* nAChRs in α6L9′S VTA DA neurons may enhance reward signals by being 
more strongly activated by endogenous ACh levels.  To test this idea, we recorded from 
VTA DA neurons in acutely-prepared brain slices from α6L9′S and control littermate 
mice.  Following visual identification and the establishment of a stable whole-cell 
recording, VTA DA neurons were held in voltage clamp mode.  A second, drug-filled 
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micropipette was used to locally deliver ACh to the recorded neuron, resulting in 
activation of nAChRs (Figure 8a; inset schematic).  ACh-evoked currents were generated 
in response to lower concentrations of ACh in α6L9′S neurons relative to neurons from 
control littermate mice (Figure 8a).  Peak current amplitudes at each of several ACh 
concentrations were plotted, and the data were fitted to the Hill equation.  In VTA DA 
neurons, the EC50 for ACh was lowered substantially in L9′S neurons compared to 
responses in control littermate neurons (non-Tg: 208 μM; α6L9′S: 2 μM; Figure 8b).  A 
similar EC50 trend was obtained from SNc DA neurons (non-Tg: 94 μM; α6L9′S: 1 μM; 
Figure 8c).  Together, these results demonstrate that nAChRs in α6L9′S VTA DA 
neurons are hypersensitive to ACh.  This may partially underlie the increased sensitivity 
to alcohol reward in α6L9′S mice. 
 
Discussion 
Previous studies have utilized nAChR subunit knockout mice or pharmacological 
blockade of nAChRs to investigate the relevant nAChR subunits involved in alcohol 
reward.  Here, we studied α6L9′S mice, which were specifically engineered to amplify 
and/or isolate functional responses following α6* nAChR activation.  α6GFP mice were 
also used to precisely localize α6* nAChRs in individual neurons in the mesolimbic 
reward system.  We found that female α6L9′S mice drank greater amounts of 3% and 6% 
alcohol solutions in a two-bottle choice paradigm.  α6L9′S of both sexes drank greater 
amounts of a 20% alcohol solution in the DID paradigm.  Further, α6L9′S mice exhibited 
CPP following injection of 0.5 g/kg alcohol, which was insufficient to produce CPP in 
littermate control mice.  Both genotypes showed evidence of CPP in the 2.0 g/kg 
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experiment, although the main effect did not quite reach statistical significance 
(p=0.057).  Our data also showed that α6* nAChRs are specifically expressed in midbrain 
DAergic (but not GABAergic) neurons (Figure 7), and that α6* nAChRs in α6L9′S mice 
are dramatically more sensitive to endogenous ACh (Figure 8), suggesting that DA 
reward signals following alcohol exposure are enhanced in α6L9′S mice.  Taken together, 
these results suggest that genotype, sex and alcohol concentration are interacting to 
influence sensitivity to the rewarding effects of alcohol.    
α6* nAChRs in alcohol reward-related behaviors 
Interest in studying the modulation of alcohol’s rewarding effects by the nicotinic 
cholinergic system stems from the high co-morbidity between tobacco addiction and 
alcohol use disorders (AUDs) (Dani & Harris, 2005).  Nicotine and/or alcohol 
interactions at specific nAChR subtypes may explain the co-morbidity.  Indeed, particular 
alleles in either of the α5-α3-β4 or α6-β3 nAChR gene clusters have been associated with 
increased risk toward development of nicotine addiction and AUDs in humans (Hoft et 
al., 2009, Wang et al., 2009), though 5* nAChRs do not play a role in alcohol 
consumption in mice (Santos et al., 2012).    
Enhanced alcohol consumption in female α6L9′S mice in the 24-hr drinking 
experiment and in both male and female α6L9′S mice for the DID experiment is 
consistent with prior studies in which nAChR subtypes have been implicated in alcohol 
intake and alcohol reward.  Mecamylamine, a non-specific nAChR antagonist, reduced 
voluntary alcohol intake using both 24-hr and limited-access drinking procedures 
(Blomqvist et al., 1996, Le et al., 2000), and reduced alcohol intake in a binge-drinking 
paradigm (Hendrickson et al., 2009).  Varenicline, an FDA-approved smoking cessation 
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drug and partial agonist at α4β2* and α6β2* nAChRs (Bordia et al., 2012, Mihalak et al., 
2006) acts via VTA nAChRs to attenuate alcohol consumption (Hendrickson et al., 2010, 
Zhao-Shea et al., 2011).  Mice lacking α4 nAChR subunits – a genetic alteration that 
dramatically reduces α6* nAChR function (Drenan et al., 2010) – show significantly less 
alcohol consumption than mice with intact α4* nAChR function (Hendrickson et al., 
2010).  Although mice lacking 6 nAChR subunits (6KO mice) demonstrated increased 
sensitivity to the sedative-hypnotic effects of high alcohol concentrations, they did not 
show differences in alcohol consumption (Kamens et al., 2012).  These results could be 
due to 42* nAChR up-regulation, which is seen in 6KO DA terminals (Champtiaux 
et al., 2003).  Importantly, blockade of α6* nAChRs in the VTA with α-conotoxin MII 
reduced locomotor activity, accumbal DA release, and the rewarding action of alcohol 
(Larsson et al., 2004).  Local VTA infusion of α-conotoxin MII also blocked alcohol-
associated conditioned responding (Larsson et al., 2004).  These pharmacological and/or 
genetic loss-of-function studies of α4* and α6* nAChRs complement the data we present 
here; prior results in mice with diminished function at α4* or α6* nAChRs showed 
reduced alcohol consumption or reward, and in this paper, enhanced α6* nAChR function 
is associated with enhanced sensitivity to the rewarding effects of alcohol.  
Intriguingly, we found a sex-dependent genotype difference in alcohol intake at 
the 3% and 6% concentrations, such that female α6L9′S mice drank significantly more 
than female non-Tg mice (Figure 1).  These differences in alcohol intake are not related 
to polydipsia since both genotypes consumed similar amounts of total fluid, which 
implies the observed differences are specific to alcohol.  Future studies comparing intake 
of other tastants (e.g. saccharine/quinine preference) will be important and allow for 
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assessment of reward-related genotype differences with other reinforcers.  These 
results suggest a leftward shift in the alcohol reward dose response curve in female 
α6L9′S mice.  It is interesting to note that while sex-dependent genotype differences were 
uncovered in the 24-hr drinking paradigm, there were no significant sex-dependent 
effects in DID or the expression of CPP.  α6L9′S mice, due to the discrete and well-
described nature of their genetic alteration, will be useful in future studies to model sex 
differences in alcohol and/or nicotine reinforcement.     
The increased sensitivity to alcohol-induced CPP at the 0.5 g/kg dose in α6L9′S 
mice provides further support for the idea that the L9′S mutation produced a leftward 
shift in the dose-response curve for alcohol reward in these mice (Figure 4).  Similarly, 
Liu and colleges (2012a) recently reported CPP with  a 0.5 g/kg alcohol dose in mice 
with hypersensitive α4* nAChRs (Leu9′Ala) but not in WT mice; no genotype difference 
was seen with 2.0 g/kg alcohol-induced CPP.  Interestingly, α6 subunits are co-expressed 
with α4 subunits in VTA DAergic neurons (Champtiaux et al., 2003, Liu et al., 2012b), 
suggesting that α6* and α4*, or possibly α6α4* nAChRs, are involved in modulating 
alcohol reward-related behavior.   
Although we observed no genotype differences in the locomotor-activating effects 
of alcohol during the CS+ conditioning trials, genotype differences were observed in the 
absence of alcohol.  Non-Tg mice were more active than α6L9′S mice during both the 
pretest and posttest of the 0.5 g/kg alcohol study, but not the 2.0 g/kg study.  This result is 
inconsistent with a previous report indicating greater home-cage activity in α6L9′S than 
non-Tg mice (Cohen et al., 2012, Drenan et al., 2010, Drenan et al., 2008), but it could 
be explained by environmental or procedural factors that differ between this and the prior 
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study.  It should be noted that the genetic background of the α6L9′S mice in both studies 
was C57BL/6.   
Correlations between CS+ time and activity during the posttest yielded a 
significant negative relationship in non-Tg but not in α6L9′S mice in the 2.0 g/kg CPP 
experiment; no correlation was found in the 0.5 g/kg alcohol experiment.  Gremel and 
Cunningham (2007) have previously shown a negative relationship between CPP 
magnitude and test activity, suggesting that higher levels of activity interfere with the 
expression of CPP (Gremel & Cunningham, 2007).  This negative relationship found in 
the non-Tg mice (and lack thereof in the α6L9′S mice) may explain the weaker 2.0 g/kg 
alcohol-induced CPP in the α6L9′S mice (Figure 6).   
α6* nAChR neurobiology and the response to alcohol 
Studies of the behavioral and neurobiological action of α6* nAChRs are of 
intense interest for two key reasons: 1) α6* nAChRs respond robustly to concentrations 
of nicotine that are well within the physiological range of nicotine concentrations found 
in the cerebrospinal fluid of smokers (Salminen et al., 2007), implicating their role in 
nicotine addiction and as targets for smoking cessation drugs (Quik & Mcintosh, 2006), 
and 2) α6* nAChRs are selectively expressed in only a few brain regions (Azam et al., 
2002, Champtiaux et al., 2002, Drenan et al., 2008, Le Novere et al., 1996), the most 
important being the mesolimbic and nigrostriatal DA systems.  Selective manipulation of 
nAChR activity in these neurotransmitter systems by α6* nAChR agonists, antagonists, 
or positive allosteric modulators could provide new avenues for development of 
treatments for Parkinson’s disease, smoking cessation, and AUDs (Drenan & Lester, 
2012).   
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 Alcohol’s action in the brain is complex, likely involving a variety of interactions 
at specific neurotransmitter receptors, ion channels, and brain circuits in a concentration-
dependent manner (Morikawa & Morrisett, 2010).  VTA DA neuron activity, 
specifically, baseline spontaneous firing rate, and the transition from tonic to phasic firing 
are key neural correlates of alcohol reward (Pfeffer & Samson, 1988, Rassnick et al., 
1992).  Cholinergic excitation of nAChRs is permissive for activation of DA neuron 
phasic firing (Mameli-Engvall et al., 2006) and for self administration of several drugs of 
abuse (Corrigall et al., 1994).  Alcohol has well-known effects on GABAA receptors 
(Whitten et al., 1996) and NMDA receptors (Lovinger et al., 1989, Maldve et al., 2002), 
that likely play a role in  alcohol addiction.  Importantly, several studies support the idea 
that alcohol may directly potentiate nAChR activity in VTA DA neurons.  Co-application 
of alcohol was sufficient to potentiate peak current amplitude of β4* nAChRs (Borghese 
et al., 2002, Covernton & Connolly, 1997), α-bungarotoxin insensitive nAChRs in 
primary cortical neurons (Aistrup et al., 1999, Marszalec et al., 1999), and α4β2 nAChRs 
(Zuo et al., 2001, Zuo et al., 2002).  Based on these studies and the results we present in 
this paper, alcohol may also potentiate α6* nAChR responses.  Future studies will be 
required to address this hypothesis. 
 In patch-clamp recordings from VTA DA neurons in acute brain slices, activation 
of nAChRs with low concentrations of nicotine potentiated an alcohol-induced increase 
in action potential firing (Clark & Little, 2004).  Furthermore, Taylor and colleagues 
demonstrated that infusion of nicotine into VTA was sufficient to summate with low-
concentrations of alcohol to enhance DA release in nucleus accumbens (Tizabi et al., 
2002).  These results suggest that low-concentrations of alcohol or low-levels of nAChR 
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activity, which alone may not be sufficient to support changes in behavior, may combine 
to produce sufficient DA neuron activity to produce the rewarding effects of alcohol.  In 
α6L9′S mice, stronger levels of ACh-activated α6* nAChR activity (Figure 8) may 
combine with alcohol concentrations that are normally subthreshold (3-6% solutions: 
Figure 1; 0.5 g/kg alcohol: Figure 4) to produce sufficient stimulation of the mesolimbic 
DA system to produce alcohol reward.  This supposition is strongly supported by recent 
VTA DA neuron patch clamp experiments with hypersensitive α4* nAChR mice, where 
alcohol was able to summate with bath-applied ACh to increase firing rates specifically 
via α4* nAChRs (Liu et al., 2012a). 
Conclusions 
The present study is the first to directly demonstrate a role for α6* nAChRs in 
modulating alcohol reward-related behaviors.  The data suggest that α6L9′S mice are 
more sensitive to alcohol reward, likely a result of hypersensitive α6* nAChRs.  These 
results using gain-of-function nAChRs expressed in mice, together with the emerging 
literature detailing the roles of α6* nAChRs in DA neurobiology (Drenan et al., 2010, 
Drenan et al., 2008, Mackey et al., 2012), suggest that α6* nAChRs are a promising 
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Figure 1.  Data are shown as two-day averages (±SEM) of 24-hr two-bottle choice (a) 
alcohol (g/kg) and (b) total fluid (ml/kg) intake for male (left panels) and female (right 
panels) α6L9′S and non-Tg mice. Female α6L9′S mice drank greater amounts of 3% and 
6% alcohol solutions. No differences in total fluid intake were observed.  * Indicates a 
significant difference of genotype (p<0.05); # indicates a significant difference of 
genotype collapsed across sex (p<0.01). 
 
Figure 2.  Data are shown as mean (±SEM) alcohol intake (g/kg) collapsed across the 4 
days for male and female α6L9′S and non-Tg mice.  α6L9′S mice showed greater binge-
like alcohol drinking (DID) than non-Tg mice.  *Indicates a significant main effect of 
genotype (p<0.05). 
 
Figure 3.  Data are shown as mean (±SEM) activity counts for α6L9′S and non-Tg mice 
during CS+ and CS- trials using a 0.5 g/kg conditioning dose of alcohol.  Only activity 
from trials 1 and 4 are shown to simplify data presentation; trials 2 and 3 showed a 
similar pattern of activity differences as trial 4.  Female α6L9′S mice were more active 
than male α6L9′S mice and non-Tg mice showed significantly greater activity on CS+ 
trials than CS- trials.   * indicates a main effect of trial type (p<0.05; CS+ vs. CS-); # 
indicates significantly different from male α6L9′S mice (p<0.01). 
 
Figure 4.  Data are shown as mean (±SEM) change in time (sec/min) spent on the 
alcohol-paired floor between posttest and pretest (posttest – pretest difference score) for 
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α6L9′S and non-Tg mice, during the first and last 30 min of the preference tests. Note 
that a bar above the 0 line indicates a preference for the alcohol paired cue, whereas a bar 
below the 0 line is indicates an aversion.  Both male and female α6L9′S mice displayed a 
significant increase in time spent on the alcohol-paired floor as a result of conditioning 
with a 0.5 g/kg dose of alcohol, indicating that α6L9′S mice are more sensitive to the 
rewarding effects of alcohol.  *Indicates main effect of genotype (p<0.05).  
 
Figure 5.  Data are shown as mean (±SEM) activity counts for α6L9′S and non-Tg mice 
during CS+ and CS- trials using a 2.0 g/kg dose of alcohol.  All mice showed increased 
activity on CS+ trials 2-4 compared to CS- trials 2-4.  All mice also showed habituation 
of activity across CS- trials.  Only activity from trials 1 and 4 are shown to simplify data 
presentation. * indicates a main effect of trial type (p<0.01; CS+ vs. CS-); # indicates 
significantly different from Trial 1 CS- (p<0.01). 
 
Figure 6.  Data are shown as mean (±SEM) change in time (sec/min) spent on the 
alcohol-paired floor between posttest and pretest (posttest – pretest difference score) for 
α6L9′S and non-Tg mice, during the first and last 30 min of the preference tests.   Note 
that a bar above the 0 line indicates a preference for the alcohol paired cue.  Analysis 
indicated a main effect of test (p=0.057) very close to significance.   
 
Figure 7.  α6* nAChRs are selectively expressed in midbrain DA neurons.  Ventral 
midbrain sections from transgenic α6GFP mice were stained with anti-GFP and anti-TH 
(a) or anti-GFP and anti-GAD67 (b) antibodies and imaged using confocal microscopy.  
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High resolution scans at the border between the DA neuron-rich SNc and the GABA 
neuron-rich SNr (b, white box) were made, showing that α6* nAChRs are excluded from 
GABA neurons (c). 
 
Figure 8.  nAChRs in midbrain DA neurons of α6L9′S mice are hypersensitive to ACh.  
VTA DA neurons in acutely prepared brain slices from α6L9′S or non-Tg littermate mice 
were studied with whole-cell patch clamp recordings.  A range of ACh concentrations 
were directly applied to the recorded DA neuron using a puffer pipette (a, inset), resulting 
in nAChR-mediated inward currents in α6L9′S and non-Tg cells (a).  Concentration-
response curves for ACh-activated inward currents in VTA (b) and SNc (c) DA neurons 
were generated from the experimental data described in (a).                 
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